COMMUNIQUÉS West-GlobeNewswire

Canadians Come Together to Make Positive Impact During Multiple Sclerosis Awareness Month This May
24/04/2024
MS Canada welcomes people across the nation to support the MS community by participating in its signature initiatives as they work toward a world free from MS TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- May is Multiple [...]
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2024 Annual Meeting
24/04/2024
More than 25 Doheny Scientists Selected to Give Talks and Present Papers and Posters; Director of Artificial Intelligence & Imaging Research SriniVas R. Sadda, MD, to Step Into Role as ARVO President PASADENA, Calif [...]
Novo Nordisk A/S - Articles of Association, April 2024
24/04/2024
Novo Nordisk's Articles of Association, April 2024 Attachment Articles of Association 24 Apr 2024
Novo Nordisk A/S – Reduction of the share capital
24/04/2024
Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by cancellation of part of the [...]
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
24/04/2024
Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy endpoint of [...]
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
24/04/2024
COPENHAGEN, Denmark, April 24, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing [...]
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
24/04/2024
CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its first- [...]
Smart for Life Appoints Prominent Industry Executive David Trosin to Company’s Advisory Board
24/04/2024
Managing Director of Health Sciences Certification at NSF International Joins Highly Diversified Team of Advisors at Smart for Life MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart [...]
BriaCell Announces Oral and Poster Presentations at ASCO 2024
24/04/2024
Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MD Two poster presentations include Drs. Hurvitz (Fred Hutchinson Cancer Center), Brufsky (UPMC), and Cristofanilli (Weill Cornell [...]
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
24/04/2024
Strategic Audit Completion Set to Enhance BioStem Technologies' Market Position and Shareholder Value POMPANO BEACH, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative [...]
Scilex Holding Company Announces $15 Million Registered Direct Offering
24/04/2024
PALO ALTO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
24/04/2024
CHATHAM, N.J., April 24, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, [...]
LifeMD to Report First Quarter 2024 Financial Results on May 8
24/04/2024
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2024 [...]
Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer
24/04/2024
Dr. Goncalves, former CMO at Cara Therapeutics, joins Oruka as CMO Eugenia Levi, PharmD, former Head of Global Medical Affairs for Cosentyx at Novartis, also joins as VP, Medical Affairs WALTHAM, Mass., April 24, 2024 ( [...]
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
24/04/2024
First non-immunosuppressive therapy for the treatment of IgA nephropathy (IgAN) approved in Europe Conditional marketing authorization is based on statistically significant and clinically meaningful results from the [...]
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
24/04/2024
NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today [...]
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
24/04/2024
The BPL-003 Phase 2a trial is an open-label study investigating BPL-003 as both monotherapy and adjunctive to SSRIs in patients with Treatment Resistant Depression. Initial results from the recently completed [...]
PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024
24/04/2024
PETACH TIKVA, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report [...]
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
24/04/2024
DURHAM, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly [...]

Pages